title: Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States.
authors: a Section of Hematology, Department of Internal Medicine , Yale School of Medicine , New Haven , CT , USA.|b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.
authors: Amer M
authors: AM
authors: Zeidan
authors: b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.|c Department of Chronic Disease Epidemiology , Yale School of Public Health , New Haven , CT , USA.
authors: Rong
authors: R
authors: Wang
authors: b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.
authors: Cary P
authors: CP
authors: Gross
authors: a Section of Hematology, Department of Internal Medicine , Yale School of Medicine , New Haven , CT , USA.|b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.
authors: Steven D
authors: SD
authors: Gore
authors: a Section of Hematology, Department of Internal Medicine , Yale School of Medicine , New Haven , CT , USA.|b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.
authors: Scott F
authors: SF
authors: Huntington
authors: a Section of Hematology, Department of Internal Medicine , Yale School of Medicine , New Haven , CT , USA.
authors: Thomas
authors: T
authors: Prebet
authors: d Division of Population Sciences, Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , MA , USA.
authors: Gregory A
authors: GA
authors: Abel
authors: b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.|e Department of Health Policy and Management , Yale School of Public Health , New Haven , CT , USA.
authors: Amy J
authors: AJ
authors: Davidoff
authors: b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.|c Department of Chronic Disease Epidemiology , Yale School of Public Health , New Haven , CT , USA.
authors: Xiaomei
authors: X
authors: Ma
mesh_terms: D000754:Anemia, Refractory, with Excess of Blasts / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics / Q000401:mortality*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019175:DNA Methylation / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents